LEVULAN_KERASTICK: profile and news






DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ...  Feb 6, 2006
Levulan ® Kerastick ® unit sales to end-users totaled 31,506 and 100,668 in the three and twelve month periods ended December 31, 2005, respectively. ... - CCNMatthews (press release),

Dusa Pharma Shares Plummet on Acne Study  Feb 1, 2006
The therapy is designed to be a two-step process that starts with Dusa's Levulan Kerastick solution to prime the skin, making affected areas more sensitive to ... - Houston Chronicle,

DUSA Pharmaceuticals Reports Fourth Quarter and Full Year 2005 ...  Feb 6, 2006
Levulan ® Kerastick ® unit sales to end-users totaled 31,506 and 100,668 in the three and twelve month periods ended December 31, 2005, respectively. ... - CCNMatthews (press release),

Dusa Pharma Shares Plummet on Acne Study  Feb 1, 2006
The therapy is designed to be a two-step process that starts with Dusa's Levulan Kerastick solution to prime the skin, making affected areas more sensitive to ... - Houston Chronicle,

DUSA Pharmaceuticals Announces Exclusive Agreement With Stiefel ...  Jan 18, 2006
The agreement covers current and future uses of DUSA's proprietary Levulan ® Kerastick ® for photodynamic therapy (PDT) in dermatology. ... - CCNMatthews (press release),

DUSA Pharmaceuticals Announces Exclusive Agreement With Stiefel ...  Jan 18, 2006
WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 18, 2006 - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA), announced today that it has entered ... - PharmaLive.com (press release),

Cancer treatment also may help heal acne, sun damage, some say  Sep 26, 2005
The procedure involves applying a topical solution called 5-aminolevulinic acid (Levulan Kerastick) directly to the skin, then activating it with a light ... - DetNews.com,

Dusa Announces Second Quarter 2005 Levulan Kerastick And BLU-U ...  Jul 14, 2005
WILMINGTON, Mass.--(BUSINESS WIRE)--Jul 14, 2005 - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) today announced second quarter (Q2 ... - PharmaLive.com (press release)

DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second ...  Jul 12, 2005
...(NASDAQ NMS:DUSA) announces that an update regarding second quarter Levulan Kerastick and BLU-U end user sales will be issued after the close on Thursday July ... - PharmaLive.com (press release)

DUSA Announces Increased First Quarter 2005 Levulan Kerastick and ...  Apr 12, 2005
WILMINGTON, Mass.--(BUSINESS WIRE)--Apr 12, 2005 - DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) today announced increased first ... - PharmaLive.com,


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org